Boothbay Fund Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Boothbay Fund Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,057	Closed	-$14.9K	–	2572
2023 Q1	$14.9K	Hold	45,057	–	–	﹤0.01%	2068
2022 Q4	$32.4K	Hold	45,057	–	–	﹤0.01%	1903
2022 Q3	$54K	Sell	45,057 -4,740	-10%	-$6.04K	﹤0.01%	2110
2022 Q2	$59K	Hold	49,797	–	–	﹤0.01%	2065
2022 Q1	$108K	Hold	49,797	–	–	﹤0.01%	2078
2021 Q4	$74K	Hold	49,797	–	–	﹤0.01%	1748
2021 Q3	$145K	Sell	49,797 -3,244	-6%	-$9.89K	﹤0.01%	1706
2021 Q2	$175K	Hold	53,041	–	–	0.01%	1572
2021 Q1	$199K	Hold	53,041	–	–	0.01%	1365
2020 Q4	$187K	Buy	+53,041	New	+$224K	0.01%	1112
2018 Q3	–	Sell	-8,080	Closed	-$596K	–	982
2018 Q2	$596K	Buy	+8,080	New	+$630K	0.05%	297

Other funds holding BLCM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Boothbay Fund Management's BLCM Position: Q2 2023 in Review

Boothbay Fund Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 45,057 shares — an estimated $14.9K sold.

Boothbay Fund Management first reported a position in BLCM in Q2 2018 and held it in 11 quarters. The position peaked at $596K in Q2 2018. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

Boothbay Fund Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Boothbay Fund Management sold 45,057 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $14.9K.
Boothbay Fund Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2018 and held it in 11 quarters.
Boothbay Fund Management's Bellicum Pharmaceuticals, Inc. position peaked at $596K in Q2 2018.
4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.